© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Fidelity Advisor Biotechnology Fund (FBTIX) stock declined over -0.02%, trading at $52.99 on NASDAQ, down from the previous close of $53.00. The stock opened at $53.00, fluctuating between $52.99 and $53.00 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 53.00 | 53.00 | 52.99 | 52.99 | 0 |
| Sep 10, 2026 | 53.53 | 53.53 | 53.00 | 53.00 | 0 |
| Sep 09, 2026 | 54.30 | 54.30 | 53.53 | 53.53 | 0 |
| Sep 08, 2026 | 54.97 | 54.97 | 54.30 | 54.30 | 0 |
| Sep 04, 2026 | 55.08 | 55.08 | 54.97 | 54.97 | 0 |
| Sep 03, 2026 | 54.42 | 55.08 | 54.42 | 55.08 | 0 |
| Sep 02, 2026 | 54.42 | 55.11 | 54.42 | 55.11 | 0 |
| Sep 01, 2026 | 54.18 | 54.42 | 54.18 | 54.42 | 0 |
| Aug 31, 2026 | 54.08 | 54.18 | 54.08 | 54.18 | 0 |
| Aug 28, 2026 | 55.73 | 55.73 | 54.08 | 54.08 | 0 |
| Aug 27, 2026 | 56.08 | 56.08 | 55.73 | 55.73 | 0 |
| Aug 26, 2026 | 55.88 | 56.08 | 55.88 | 56.08 | 0 |
| Aug 25, 2026 | 55.88 | 56.79 | 55.88 | 56.79 | 0 |
| Aug 24, 2026 | 56.33 | 56.33 | 55.88 | 55.88 | 0 |
| Aug 21, 2026 | 55.70 | 56.33 | 55.70 | 56.33 | 0 |
| Aug 20, 2026 | 57.68 | 57.68 | 55.70 | 55.70 | 0 |
| Aug 19, 2026 | 54.81 | 57.68 | 54.81 | 57.68 | 0 |
| Aug 18, 2026 | 52.74 | 54.81 | 52.74 | 54.81 | 0 |
| Aug 17, 2026 | 52.74 | 53.46 | 52.74 | 53.46 | 0 |
| Aug 14, 2026 | 52.82 | 52.82 | 52.74 | 52.74 | 0 |
Boston, MA 2210
United States
https://fundresearch.fidelity.com/mutual-funds/summary/315918466877 208 0098"This fund primarily invests in common stocks. Typically, at least 80% of its assets are dedicated to companies actively involved in the discovery, advancement, production, and sale of biotechnology-related offerings (products, services, and processes), as well as companies positioned to significantly gain from scientific and technological breakthroughs in biotechnology. The fund's holdings include both U.S. and foreign companies. Investment decisions are guided by comprehensive fundamental analysis, evaluating factors like each issuer's financial stability, competitive position, and broader market and economic conditions. It is structured as a non-diversified fund."
| Employees | 0 |
| Beta | 0.63 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management |